Emerging Approaches to Cancer Immunotherapy

Emerging Approaches to Cancer Immunotherapy

Thursday, May 21, 2015

The New York Academy of Sciences

Presented By

 

Over the past several years, cancer immunotherapy has made extraordinary progress both conceptually and in clinical practice. Led by landmark studies in the setting of metastatic melanoma, many of the findings of this field are being generalized both to hematological malignancies and to other solid tumors. Areas of investigation such as checkpoint blockade inhibitors, advanced tumor vaccination studies, and adoptive T-cell therapies are changing the face of cancer treatment. This symposium will bring together leading experts in immunotherapy and immunology to discuss these emerging approaches, along with the challenges and opportunities faced in this evolving field.

*Reception to follow.

This event will also be broadcast as a webinar.

Please note: Transmission of presentations via the webinar is subject to individual consent by the speakers. Therefore, we cannot guarantee that every speaker's presentation will be broadcast in full via the webinar. To access all speakers' presentations in full, we invite you to attend the live event in New York City when possible.

Registration and Webinar Pricing

Member$30
Student/Postdoc Member$15
Nonmember (Academia)$65
Nonmember (Corporate)$85
Nonmember (Non-profit)$65
Nonmember (Student / Postdoc / Resident / Fellow)$45


Mission Partner support for the Frontiers of Science program provided by   Pfizer

Agenda

* Presentation titles and times are subject to change.


May 21, 2015

9:00 AM

Welcome and Introductory Remarks
Sonya Dougal, PhD, The New York Academy of Sciences
Kenneth P. Olive, PhD, Columbia University Medical Center

9:15 AM

Keynote Address
Chimeric Antigen Receptor Modified T cells for Blood Cancers: Clinical Results
Carl June, MD, University of Pennsylvania

10:00 AM

Antigen Specific Adoptive T Cell Immunotherapy for Treatment of Cancer
Stephen J. Forman, MD, FACP, City of Hope

10:35 AM

Networking Coffee Break

11:05 AM

Bi-specific T Cell Engaging Antibodies in the Treatment of Acute Lymphoblastic Leukemia
Mark R. Litzow, MD, Mayo Clinic

11:40 AM

Dendritic Cell Based Immunotherapy for Cancer
Marnix Bosch, PhD, MBA, Northwest Biotherapeutics

12:10 PM

Networking Lunch and Poster Session

1:40 PM

Mechanisms of Resistance to Immunotherapies Driven by Features of the Tumor Microenvironment
Thomas Gajewski, MD, PhD, The University of Chicago Medicine

2:15 PM

Lifting the Veil of Immune Suppression and Inducing Immune Activation Through Antibody-Mediated Blockade of Phosphatidylserine Signaling
Rolf Brekken, PhD, University of Texas, Southwestern

2:45 PM

Networking Coffee Break

3:15 PM

Response and Resistance to Radiation and Immune Checkpoint Blockade in Solid Tumors
Andy Minn, MD, PhD, University of Pennsylvania

3:50 PM

Preclinical to Clinical Translation of Anti-PD-1 Blockade
Elaine Pinheiro, PhD, Merck Research Laboratories
David Kaufman, MD, PhD, Merck Research Laboratories

4:30 PM

Panel Discussion

5:10 PM

Closing Remarks
George Zavoico, PhD, Jones Trading

5:15 PM

Networking Reception

6:00 PM

Adjourn

Speakers

Organizers

Kenneth P. Olive, PhD

Columbia University Medical Center

George Zavoico, PhD

Jones Trading Co.

Sonya Dougal, PhD

The New York Academy of Sciences

Speakers

Marnix Bosch, PhD, MBA

Northwest Biotherapeutics

Rolf Brekken, PhD

University of Texas, Southwestern

Stephen J. Forman, MD, FACP

City of Hope

Thomas F. Gajewski, MD, PhD

The University of Chicago Medicine

Carl H. June, MD

University of Pennsylvania

David Kaufman, MD, PhD

Merck Research Laboratories

Mark R. Litzow, MD

Mayo Clinic

Andy Minn, MD, PhD

University of Pennsylvania

Elaine Pinheiro, MD

Merck Research Laboratories

Sponsors

For sponsorship opportunities please contact Perri Wisotsky at pwisotsky@nyas.org or 212.298.8642.

Academy Friend

Peregrine Pharmaceuticals, Inc.

Grant Support

The educational portion of this Program is supported, in part, by an independent educational grant from AstraZeneca.

Promotional Partners

Elsevier

Nature

Biotech Calendar

Immunotherapy & Vaccine Summit (ImVacs)


Mission Partner support for the Frontiers of Science program provided by   Pfizer

Travel & Lodging

Our Location

The New York Academy of Sciences

7 World Trade Center
250 Greenwich Street, 40th floor
New York, NY 10007-2157
212.298.8600

Directions to the Academy

Hotels Near 7 World Trade Center

Recommended partner hotel

Club Quarters, World Trade Center
140 Washington Street
New York, NY 10006
Phone: 212.577.1133

The New York Academy of Sciences is a member of the Club Quarters network, which offers significant savings on hotel reservations to member organizations. Located opposite Memorial Plaza on the south side of the World Trade Center, Club Quarters, World Trade Center is just a short walk to the Academy.

Use Club Quarters Reservation Password NYAS to reserve your discounted accommodations online.

Other nearby hotels

Conrad New York

212.945.0100

Millenium Hilton

212.693.2001

Marriott Financial Center

212.385.4900

Club Quarters, Wall Street

212.269.6400

Eurostars Wall Street Hotel

212.742.0003

Gild Hall, Financial District

212.232.7700

Wall Street Inn

212.747.1500

Ritz-Carlton New York, Battery Park

212.344.0800